🇺🇸 FDA
Pipeline program

TARA-002

TARA-002-201

Phase 2 mab active

Quick answer

TARA-002 for Lymphatic Malformation is a Phase 2 program (mab) at Protara Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Protara Therapeutics
Indication
Lymphatic Malformation
Phase
Phase 2
Modality
mab
Status
active

Clinical trials